Dual targeting of EZH2 and EZH1 drives exit of leukemia stem cells from quiescence and potentiates chemotherapy in acute myeloid leukemia. - Akiyama H; Nishida Y; Chang KH; Bedoy AD; Muftuoglu M; Ma W; Basyal M; Hirschi Z; Honma D; Tsutsumi S; Wang J; Zhang W; et al. (Blood cancer journal, 2025)